Novamind opens the 6th mental health clinic in its Cedar Psychiatry network, located in Murray, Utah. Novamind is now projecting a total of 65,000 clinic visits this year.
Articles
MINDCURE Announces Commencement of Trading on the OTCQX Best Market
MINDCURE announces its addition to the OTCQX Best Markets tier.
How The SAFETY Of Psychedelic Drugs Is Driving A Medical Revolution
Two billion people suffer from treatable mental health disorders resulting in 8 million preventable deaths per year. Psychedelics can address this catastrophe -- but first these drugs must be legalized.
L.A. County to Dismiss 60K Cannabis Convictions
Los Angeles County District Attorney George Gascón said on Monday that his office had identified nearly 60,000 cannabis convictions that will be dismissed under criminal justice provisions of the state’s cannabis legalization law.
California Governor Signs Bill To Allow Medical Marijuana Use In Hospitals For Severely Ill Patients
The governor of California on Tuesday signed a bill to require hospitals to permit medical marijuana use by certain patients.
New Frontier Data Predict Global Cannabis Sales to Hit $51 billion by 2025
A New Frontier Data report highlights how much the cannabis industry will grow in the next few years.
New York Prison Being Transformed Into $150 Million Cannabis Campus
New York is turning over a symbolic new leaf by prepping a former prison site to become a legal cannabis facility.
Another Michigan City Advances Psychedelics Decriminalization Support
Yet another Michigan city has approved a resolution on Tuesday calling for decriminalization of a wide range of psychedelics such as psilocybin and ayahuasca.
MINDCURE Launches "Desire Project" To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy
MINDCURE launches "Desire Project", taking a psychotherapy approach to female hypocactive sexual disorder.
Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders
Private company Delix Therapeutics raises $70 million, focusing on non-hallucinatory candidates to treat brain disorders.
Levitee Labs Announces DTC Eligibility Approval
Levitee Labs announces that its shares are now eligible for clearing through the DTC.
Novamind Announces DTC Eligibility for its Common Shares
Novamind announces that its shares are now eligible for electronic clearing through the DTC.
MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration
MindMed provides updates on two of its research initiatives, in partnership with the Liechti Lab (Switzerland).
Are Psychedelic Stocks About To Heat Up (Again)?
Recent market clues are suggesting that a much overdue rally for psychedelic stocks may be about to begin.
Feds Fund Study Into Whether Psilocybin Can Help People Quit Smoking Cigarettes
A top federal drug agency is funding a study into how psilocybin could help people quit smoking cigarettes—one of the latest examples of the government’s growing interest in psychedelic therapy.